好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Activation of HERV-K and response to antiretroviral therapy in patients with HIV infection and motor neuron disease
Global Health and Neuroepidemiology
(-)
001
Authors/Disclosures
Bryan Smith, MD (NIH)
PRESENTER
Dr. Smith has nothing to disclose.
Jaclyn B. Caccese, PhD (The Ohio State University College of Medicine) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Elyse J. Singer, MD (Dept of Neurology, David Geffen School of Medicine@UCLA) The institution of Dr. Singer has received research support from NIH. Dr. Singer has received personal compensation in the range of $1,000,000+ for serving as a Principal investigator/Study section with NIH.
Thy Nguyen, MD (University of Texas Health Science Center) Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Tanya J. Lehky, MD (National Institutes of Health) Dr. Lehky has nothing to disclose.
No disclosure on file
No disclosure on file
Tariq B. Alfahad, MD No disclosure on file
Joseph R. Berger, MD, FAAN Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Avindra Nath, MD, MBBS, FAAN (National Institutes of Health) Dr. Nath has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from ALS Association. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.